30 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Pharma Stock Roundup: LLY's New Digital Pharmacy, NVO & ABBV's Fresh R&D Deals https://www.zacks.com/stock/news/2206363/pharma-stock-roundup-lly-s-new-digital-pharmacy-nvo-abbv-s-fresh-r-d-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2206363 Jan 05, 2024 - Eli Lilly (LLY) launches a new direct-to-consumer website to provide easy access to its medicines. Novo Nordisk (NVO) announces two research collaborations to develop novel treatments for cardiometabolic diseases.
Dominion Energy (D) Stock Declines While Market Improves: Some Information for Investors https://www.zacks.com/stock/news/2215362/dominion-energy-d-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2215362 Jan 24, 2024 - The latest trading day saw Dominion Energy (D) settling at $44.15, representing a -1.45% change from its previous close.
NextEra Energy (NEE) Q4 Earnings & Revenues Beat Estimates https://www.zacks.com/stock/news/2216056/nextera-energy-nee-q4-earnings-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2216056 Jan 25, 2024 - NextEra Energy (NEE) posts better-than-expected fourth-quarter earnings and revenues. It continues to gain from the thriving Florida economy.
2seventy bio (TSVT) Divests R&D Assets to Regeneron, Stock Up https://www.zacks.com/stock/news/2218877/2seventy-bio-tsvt-divests-r-d-assets-to-regeneron-stock-up?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2218877 Jan 31, 2024 - 2seventy bio (TSVT) inks an asset purchase agreement with Regeneron to sell its oncology and autoimmune pipeline to the latter.
Exelixis (EXEL) Q4 Earnings Beat on Lower R&D Spend, Sales Miss https://www.zacks.com/stock/news/2222832/exelixis-exel-q4-earnings-beat-on-lower-r-d-spend-sales-miss?cid=CS-ZC-FT-analyst_blog|earnings_article-2222832 Feb 07, 2024 - Exelixis (EXEL) surpasses earnings estimates in the fourth quarter on lower R&D expenses. Sales, however, miss estimates.
Can Southern (SO) Q4 Earnings Maintain Its Beat Streak? https://www.zacks.com/stock/news/2223998/can-southern-so-q4-earnings-maintain-its-beat-streak?cid=CS-ZC-FT-analyst_blog|earnings_preview-2223998 Feb 09, 2024 - Customer additions and lower costs are likely to have boosted The Southern Company's (SO) profit levels in the fourth quarter.
ONE Gas (OGS) to Post Q4 Earnings: What's in the Offing? https://www.zacks.com/stock/news/2227416/one-gas-ogs-to-post-q4-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2227416 Feb 16, 2024 - ONE Gas' (OGS) Q4 earnings are likely to have gained from customer growth and the implementation of new rates, while increasing expenses might have offset the upsides.
Dominion Energy (D) to Post Q4 Earnings: What's in Store? https://www.zacks.com/stock/news/2228102/dominion-energy-d-to-post-q4-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2228102 Feb 19, 2024 - Dominion Energy's (D) fourth-quarter results are likely to benefit from higher sales volume, while the high interest rate and planned outage of Millstone Power Station will offset some positives.
Insiders Are Buying These 5 Stocks https://www.zacks.com/stock/news/2237695/insiders-are-buying-these-5-stocks?cid=CS-ZC-FT-stocks_in_the_news-2237695 Mar 07, 2024 - Many investors closely monitor insider buys, as they can provide insight into the longer-term picture. And recently, insiders of these five companies have made splashes.
Dominion Energy (D) Stock Dips While Market Gains: Key Facts https://www.zacks.com/stock/news/2239615/dominion-energy-d-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2239615 Mar 12, 2024 - The latest trading day saw Dominion Energy (D) settling at $46.98, representing a -1.39% change from its previous close.

Pages: 123

<Page 2